Healthcare Ebitda from 2010 to 2025

HCTI Stock  USD 0.35  0.02  5.41%   
Healthcare Triangle's EBITDA is decreasing with slightly volatile movements from year to year. EBITDA is predicted to flatten to about -4.3 M. For the period between 2010 and 2025, Healthcare Triangle, EBITDA quarterly trend regression had median of  2,445,195 and r-value of (0.79). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-4.1 M
Current Value
-4.3 M
Quarterly Volatility
3.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Healthcare Triangle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Triangle's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1 M or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 0.38, Dividend Yield of 0.0 or PTB Ratio of 26.09. Healthcare financial statements analysis is a perfect complement when working with Healthcare Triangle Valuation or Volatility modules.
  
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.

Latest Healthcare Triangle's Ebitda Growth Pattern

Below is the plot of the Ebitda of Healthcare Triangle over the last few years. It is Healthcare Triangle's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthcare Triangle's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Healthcare Ebitda Regression Statistics

Arithmetic Mean67,386
Coefficient Of Variation5,414
Mean Deviation3,211,327
Median2,445,195
Standard Deviation3,648,527
Sample Variance13.3T
Range9.5M
R-Value(0.79)
Mean Square Error5.4T
R-Squared0.62
Significance0.0003
Slope(604,873)
Total Sum of Squares199.7T

Healthcare Ebitda History

2025-4.3 M
2024-4.1 M
2023-6 M
2022-7 M
2021-3.9 M
2020M

About Healthcare Triangle Financial Statements

Investors use fundamental indicators, such as Healthcare Triangle's Ebitda, to determine how well the company is positioned to perform in the future. Although Healthcare Triangle's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA-4.1 M-4.3 M

Currently Active Assets on Macroaxis

When determining whether Healthcare Triangle offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Triangle's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Triangle Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Triangle Stock:
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.17)
Revenue Per Share
3.377
Quarterly Revenue Growth
(0.69)
Return On Assets
(0.60)
Return On Equity
(4.62)
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.